Use of b7rp1 antagonists in ige-mediated disorders
CA 2429599 A1 · Owner: Mak, Tak Wah · Inventors: Shahinian, Arda; Senaldi, Giorgio; Bladt, Anna Tafuri
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel polypeptides which comprise a receptor-ligand pair involved in T-cell activation are disclosed. Nucleic acid molecules encoding said polypeptides and vectors and host cells for expressing same are also disclosed. The polypeptides, or agonists and antagonists thereof are used to treat T-cell , mediated disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 28, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 28, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 28, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.